AU2001265252A1 - Biologically useful polyphosphates - Google Patents
Biologically useful polyphosphatesInfo
- Publication number
- AU2001265252A1 AU2001265252A1 AU2001265252A AU6525201A AU2001265252A1 AU 2001265252 A1 AU2001265252 A1 AU 2001265252A1 AU 2001265252 A AU2001265252 A AU 2001265252A AU 6525201 A AU6525201 A AU 6525201A AU 2001265252 A1 AU2001265252 A1 AU 2001265252A1
- Authority
- AU
- Australia
- Prior art keywords
- biologically useful
- polyphosphates
- useful polyphosphates
- biologically
- useful
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
- A61K47/6907—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a microemulsion, nanoemulsion or micelle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
- A61K47/6927—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores
- A61K47/6929—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores the form being a nanoparticle, e.g. an immuno-nanoparticle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G79/00—Macromolecular compounds obtained by reactions forming a linkage containing atoms other than silicon, sulfur, nitrogen, oxygen, and carbon with or without the latter elements in the main chain of the macromolecule
- C08G79/02—Macromolecular compounds obtained by reactions forming a linkage containing atoms other than silicon, sulfur, nitrogen, oxygen, and carbon with or without the latter elements in the main chain of the macromolecule a linkage containing phosphorus
- C08G79/04—Phosphorus linked to oxygen or to oxygen and carbon
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L85/00—Compositions of macromolecular compounds obtained by reactions forming a linkage in the main chain of the macromolecule containing atoms other than silicon, sulfur, nitrogen, oxygen and carbon; Compositions of derivatives of such polymers
- C08L85/02—Compositions of macromolecular compounds obtained by reactions forming a linkage in the main chain of the macromolecule containing atoms other than silicon, sulfur, nitrogen, oxygen and carbon; Compositions of derivatives of such polymers containing phosphorus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Nanotechnology (AREA)
- Dispersion Chemistry (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Polymers & Plastics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Immunology (AREA)
- Optics & Photonics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polyethers (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20826200P | 2000-05-31 | 2000-05-31 | |
US60/208,262 | 2000-05-31 | ||
PCT/US2001/017613 WO2001091725A2 (en) | 2000-05-31 | 2001-05-31 | Biologically useful polyphosphates |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001265252A1 true AU2001265252A1 (en) | 2001-12-11 |
Family
ID=22773924
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001265252A Abandoned AU2001265252A1 (en) | 2000-05-31 | 2001-05-31 | Biologically useful polyphosphates |
Country Status (3)
Country | Link |
---|---|
US (1) | US6852709B2 (en) |
AU (1) | AU2001265252A1 (en) |
WO (1) | WO2001091725A2 (en) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7345138B2 (en) * | 2001-05-14 | 2008-03-18 | Johns Hopkins Singapore Pte Ltd. | Biodegradable polyphosphates for controlled release of bioactive substances |
WO2003094971A1 (en) * | 2002-05-10 | 2003-11-20 | Johns Hopkins Singapore Pte Ltd | Cationic lipids for intracellular delivery of bioactive substances |
AU2003295636A1 (en) * | 2002-11-19 | 2004-06-15 | Genzyme Corporation | Polyionene polymers with hydrolyzable linkages |
WO2005007034A1 (en) * | 2003-07-08 | 2005-01-27 | The Children's Hospital Of Philadelphia | Steroid lipid-modified polyurethane as an implantable biomaterial, the preparation and uses thereof |
US8821859B2 (en) * | 2004-05-19 | 2014-09-02 | Agency For Science, Technology And Research | Methods and articles for the delivery of therapeutic agents |
WO2005121220A2 (en) * | 2004-06-04 | 2005-12-22 | Triton Systems, Inc. | Preparation of polyphosphonates via transesterification without a catalyst |
US7358223B2 (en) * | 2004-10-04 | 2008-04-15 | Nitto Denko Corporation | Biodegradable cationic polymers |
US20090317802A1 (en) * | 2005-12-09 | 2009-12-24 | Bhatia Sangeeta N | Compositions and Methods to Monitor RNA Delivery to Cells |
US9603941B2 (en) * | 2006-01-24 | 2017-03-28 | Minghui Chai | Method of preparing dendritic drugs |
US20100303881A1 (en) * | 2006-02-02 | 2010-12-02 | The John Hopkins University | Therapeutic Electrospun Fiber Compositions |
EP1991161B1 (en) * | 2006-02-22 | 2012-11-07 | Tyco Healthcare Group, LP | Biodegradable phosphoester polyamines |
EP2099496A2 (en) * | 2006-12-08 | 2009-09-16 | Massachusetts Institute of Technology | Delivery of nanoparticles and/or agents to cells |
JP2010526062A (en) | 2007-04-30 | 2010-07-29 | エージェンシー フォー サイエンス, テクノロジー アンド リサーチ | Methods for delivering proteins to cells |
KR20100057007A (en) * | 2007-07-09 | 2010-05-28 | 글렌 에스. 권 | Micelle encapsulation of therapeutic agents |
US8999945B2 (en) | 2008-06-30 | 2015-04-07 | Silenseed Ltd | Methods, compositions and systems for local delivery of drugs |
US8834861B2 (en) | 2011-03-10 | 2014-09-16 | International Business Machines Corporation | Polycarbonates for delivery of drugs and methods of preparation thereof |
CN102295778B (en) * | 2011-06-30 | 2013-11-06 | 西安交通大学 | Hyperbranched polyphosphoramidate and preparation method thereof |
WO2013040552A2 (en) | 2011-09-16 | 2013-03-21 | Georgia Health Sciences University | Methods of promoting immune tolerance |
EP3019559A4 (en) | 2013-08-22 | 2017-04-05 | Sony Corporation | Water soluble fluorescent or colored dyes and methods for their use |
CN106029059A (en) * | 2013-10-07 | 2016-10-12 | 康涅狄格大学 | Self-assembled brush block copolymer-nanoparticles for drug delivery |
US11112145B2 (en) | 2014-09-24 | 2021-09-07 | The Board Of Trustees Of The University Of Illinois | Artificial platelets for treating catastrophic bleeding |
US11084932B2 (en) | 2015-02-26 | 2021-08-10 | Sony Group Corporation | Phenylethynylnaphthalene dyes and methods for their use |
JP6806694B2 (en) | 2015-02-26 | 2021-01-06 | ソニー株式会社 | Water-soluble fluorescent dye or colored dye containing conjugated group |
WO2017173348A1 (en) | 2016-04-01 | 2017-10-05 | Sony Corporation | Ultra bright dimeric or polymeric dyes with rigid spacing groups |
CN114806218A (en) | 2016-04-01 | 2022-07-29 | 索尼公司 | Super bright dimeric or polymeric dyes |
CA3019951A1 (en) | 2016-04-06 | 2017-10-12 | Sony Corporation | Ultra bright dimeric or polymeric dyes with spacing linker groups |
JP7068192B2 (en) | 2016-05-10 | 2022-05-16 | ソニーグループ株式会社 | Compositions containing polymer dyes and cyclodextrins, and their use |
JP2019519490A (en) | 2016-05-10 | 2019-07-11 | ソニー株式会社 | Ultra bright polymer dye having a peptide backbone |
BR112018073199A2 (en) | 2016-05-11 | 2019-04-16 | Sony Corporation | ultra-bright dimeric or polymeric dyes |
WO2017214165A1 (en) | 2016-06-06 | 2017-12-14 | Sony Corporation | Ionic polymers comprising fluorescent or colored reporter groups |
US20210032277A1 (en) | 2017-10-05 | 2021-02-04 | Sony Corporation | Programmable polymeric drugs |
KR20200083605A (en) | 2017-11-16 | 2020-07-08 | 소니 주식회사 | Programmable polymeric drugs |
US20210128591A1 (en) * | 2017-12-13 | 2021-05-06 | Sony Corporation | Ionic polymers comprising biologically active compounds |
WO2019182765A1 (en) | 2018-03-19 | 2019-09-26 | Sony Corporation | Use of divalent metals for enhancement of fluorescent signals |
CN112119083B (en) | 2018-03-21 | 2024-05-24 | 索尼公司 | Polymeric tandem dyes with linker groups |
JP2021529194A (en) | 2018-06-27 | 2021-10-28 | ソニーグループ株式会社 | Polymer dye with linker group containing deoxyribose |
JP7239904B2 (en) | 2019-09-26 | 2023-03-15 | ソニーグループ株式会社 | Polymer tandem dyes with linker groups |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5194581A (en) | 1989-03-09 | 1993-03-16 | Leong Kam W | Biodegradable poly(phosphoesters) |
US5912225A (en) | 1997-04-14 | 1999-06-15 | Johns Hopkins Univ. School Of Medicine | Biodegradable poly (phosphoester-co-desaminotyrosyl L-tyrosine ester) compounds, compositions, articles and methods for making and using the same |
US6028163A (en) | 1997-06-27 | 2000-02-22 | Guilford Pharmaceuticals Inc. | Solution polymerization of high molecular weight poly(phosphoesters) in toluene |
US5846923A (en) * | 1997-07-08 | 1998-12-08 | Rhodia Inc. | Polyamphoteric phosphate ester surfactants |
-
2001
- 2001-05-31 WO PCT/US2001/017613 patent/WO2001091725A2/en active Application Filing
- 2001-05-31 AU AU2001265252A patent/AU2001265252A1/en not_active Abandoned
- 2001-05-31 US US09/871,602 patent/US6852709B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20020045263A1 (en) | 2002-04-18 |
WO2001091725A3 (en) | 2002-03-28 |
WO2001091725A9 (en) | 2003-02-06 |
US6852709B2 (en) | 2005-02-08 |
WO2001091725A2 (en) | 2001-12-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001265252A1 (en) | Biologically useful polyphosphates | |
AU9517301A (en) | Implant | |
AU2001281758A1 (en) | Biocompatible materials | |
AU2001262847A1 (en) | Language-understanding | |
AU2001292739A1 (en) | 1-oxorapamycins | |
AU2000267458A1 (en) | Hypercomputer | |
AU2001254546A1 (en) | Aminopiperidines | |
AU2001263841A1 (en) | Implant | |
AU2001239310A1 (en) | Decahydro-isoquinolines | |
AU2001220246A1 (en) | Neckphone | |
AU2001265089A1 (en) | Rc-timer scheme | |
AU2001253666A1 (en) | Distributed rendering | |
AU2002211620A1 (en) | Autoanastomosis | |
AU2001258349A1 (en) | Bisacylguanidine | |
AU2001296577A1 (en) | Chlorophyllases | |
AU2001279754A1 (en) | Indoloquinazolinones | |
AU2001285886A1 (en) | 2-guanidino-4-aryl-quinazoline | |
AU2002211128A1 (en) | Step-bike | |
AU2001290931A1 (en) | Ski-snowboard | |
AU2001293852A1 (en) | Sulfonylguanidine | |
AU2001258924A1 (en) | Microsatellite-aflp | |
AU2001281921A1 (en) | Bdellosomes | |
AU2001246864A1 (en) | Hypotensors | |
AU2001291876A1 (en) | Triazolo-epothilones | |
AU2002214354A1 (en) | Neck-phone |